Anticancer agent 313
Anticancer agent 313 is a MetAP2 inhibitor with an IC50 of 4.11 μM. Anticancer agent 313 activates the transcription factor ATF4 via a non-canonical mTORC1-dependent pathway. Anticancer agent 313 inhibits cancer cell proliferation. Anticancer agent 313 is applicable to the research of breast cancer and pancreatic cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C18H26N2O3Si
- 분자량:346.50
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
MetAp2 |
Anticancer agent 313 (compound 3) (72 h) inhibits the proliferation of 67nr, 4T1, MDA-MB-231, BxPC3 and MIA PaCa-2 cancer cell lines[1].
Anticancer agent 313 induces ATF4 expression in 67nr, MDA-MB-231 and MIA PaCa-2 cancer cell lines via an mTORC1-dependent non-canonical (eIF2α phosphorylation-independent) mechanism, but has no such effect in 4T1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:67nr, 4T1, MDA-MB-231, BxPC3, MIA PaCa-2 cells
-
Concentration:/
-
Incubation Time:72 h
-
Result:Had IC50 values of 14.4 (67nr), 2.76 (4T1), 17.32 (MDA-MB-231), 16.7 (BxPC3), 9.71 (MIA PaCa-2) μM.
Chemical Information
-
분자량 346.50
-
화학식 C18H26N2O3Si
-
SMILES
CC(C)[Si](C(C)C)(C(C)C)OC1=CC=C([N+]([O-])=O)C2=CC=CN=C21
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)